Multiple Sclerosis Clinical Trials

A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 635 clinical trials
Featured trial
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis (OPTIMUM)

Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple

  • 284 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Multicenter, Double-Blind, Placebo-Controlled Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving TECFIDERA® (Dimethyl Fumarate) Delayed-Release Capsules

A Multicenter, Double-Blind, Placebo-Controlled Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving TECFIDERA® (Dimethyl Fumarate

  • 192 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Clinical trial studying the effects of RPC1063 in RMS

Clinical trial studying the effects of RPC1063 in RMS

  • 345 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Study of NUEDEXTA in the Treatment of Pseudobulbar Affect (PBA)

Study of NUEDEXTA in the Treatment of Pseudobulbar Affect (PBA)

  • 90 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Research study for volunteers at least 18 years of age who are currently experiencing symptoms of chronic constipation

Research study for volunteers at least 18 years of age who are currently experiencing symptoms of chronic constipation

  • 285 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

  • 208 views
  • 08 Dec, 2020
  • 1 location
Featured trial
New Approaches to Dementia Heterogeneity.

This study is looking for adults who have mild cognitive impairment, Alzheimer’s, or other forms of dementia. The study is also looking for people with normal cognition, as a comparison. The study is interested in the ways that brain function changes over time with the goal of improving the ability to diagnose …

cancer
dementia, frontotemporal
stroke
multiple sclerosis
vascular dementia
  • 27 views
  • 25 May, 2021
  • 1 location
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has begun. It is unclear if, in the

  • 349 views
  • 17 Jan, 2022
  • 40 locations